Paracetamol-loaded poly(ε-caprolactone) layered silicate nanocomposites prepared using hot-melt extrusion

Journal of Pharmaceutical Sciences

Volumn 98, Issue 12, 2009, Pages 4831-4843

  Campbell, Kayleen ^a   Qi, Sheng ^b   Craig, Duncan Q M ^b   McNally, Tony ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Biodegradable polymers; Dissolution; Extrusion; Layered silicates; Nanoclay; Nanocomposite; Nanotechnology; Paracetamol; Poly( caprolactone); Polymeric drug delivery

Indexed keywords

MONTMORILLONITE; NANOCOMPOSITE; PARACETAMOL; POLYCAPROLACTONE; SILICATE;

ARTICLE; BRIGHT FIELD MICROSCOPY; CRYSTALLIZATION; HYDROGEN BOND; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION;

EID: 71649091555     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21787     Document Type: Article

References (45)

1. Chen B, Evans JRG. 2006. Poly(e-caprolactone)-clay nanocomposites: Structure and mechanical properties. Macromolecules 39:747-754. (Pubitemid 43164590)
2. Krishnamoorti R, Giannelis EP. 1997. Rheology of end-tethered polymer silicate nanocomposites. Macromolecules 30:4097-4102. (Pubitemid 127577000)
3. Lepoittevin P, Devalckenaere M, Pantoustier N, Alexandre M, Kubies D, Calberg C, Jerome R, Dubois P. 2002. Poly(e-caprolactone)/clay nanocomposites prepared by melt intercalation: Mechanical, thermal and rheological properties. Polymer 43:4017-4023. (Pubitemid 34516864)
4. Chen B, Evans JRG. 2005. X-ray diffraction studies and phase volume determinations in poly(ethylene glycol)- montmorillonite nanocomposites. Polym Int 54:807-813. (Pubitemid 40548831)
5. Hyun YH, Lim ST, Choi HJ, Jhon MS. 2001. Rheology of poly(ethylene oxide)/organoclay nanocomposites. Macromolecules 46:8084-8093.
6. Loyens W, Jannasch P, Maurer FHJ. 2005. Effect of clay modifier and matrix molar mass on the structure and properties of poly(ethylene oxide)/Cloisite nanocomposites via melt-compounding. Polymer 46:903-914. (Pubitemid 40103488)
7. Chang J-H, An YU, Cho D, Giannelis EP. 2003. Poly(lactic acid) nanocomposites: Comparison of their properties with montmorillonite and synthetic mica (II). Polymer 44:3715-3720.
8. Nam OH, Kaneko M, Ninomiya N, Fujimori A, Musuko T. 2005. Melt intercalation of poly(L-lactide) chains into clay galleries. Polymer 46:7403-7407. (Pubitemid 41125197)
9. Ray SS, Maiti P, Okamato M, Yamada K, Ueda K. 2002. New polylactide/layered silicate nanocomposites. 1. Preparation, characterization and properties. Macromolecules 35:3104-3110.
10. Koo CM, Ham HT, Choi MH, Kim SO, Chung IJ. 2003. Characteristics of polyvinylpyrrolidone-layered silicate nanocomposites prepared by attrition ball milling. Polymer 44:681-689.
11. Pucciariello R, Villani V, Belviso S, Gorraasi G, Tortora M, Vittoria V. 2004. Phase behaviour of modified montmorillonite-poly(e-caprolactone) nanocomposites. J Polym Sci Part B Polym Phys 42:1321-1332.
12. Avella M, Bondioli F, Cannillo V, Di Pace E, Errico ME, Ferrari AM. 2006. Poly(e-caprolactone)-based nanocomposites: Influence of compatibilization on properties of poly(e-caprolactone)-silica nanocomposites. Comp Sci Tech 66:886-894. (Pubitemid 43380454)
13. Brietenbach J. 2002. Melt-extrusion from process to drug delivery. Eur J Pharm Biopharm 54:107-117.
14. Sprockel OL, Sen M, Shivanand P, Prapaitrakul W. 1997. A melt-extrusion process for manufacturing matrix drug delivery systems. Int J Pharm 155:191-199. (Pubitemid 27380405)
15. Bruce LD, Shah NA, Malick AW, Infeld MH, McGinty JW. 2005. Properties of hot-melt extruded tablet formulations for colonic delivery of 5-amino salicylic acid. Eur J Pharm Biopharm 59:85-97.
16. Rosenburg J, Ulrich R, Liepold B, Berngl G, Brientenbach J, Alani LI. 2005. Inventors; Abbott Laboratories, assignee. Solid Pharmaceutical dosage formulation. USA Patent 20050143404.
17. Repka MA, Prodduturi S, Stodghill SP. 2003. Production and characterization of hot-melt extruded films containing clotrimazole. Drug Dev Ind Pharm 29:757-765. (Pubitemid 36899882)
18. Crowley MM, Zhang F, Koleng JJ, McGinity JW. 2002. Stability of polyethylene oxide in matrix tablets prepared by hot-melt extrusion. Biomaterials 23:421-4248. (Pubitemid 34814993)
19. Hulsmann D, Backensfeld T, Keital S, Bodmeier R. 2000. Melt extrusion - An alternative method for enhancing the dissolution rate of 17B-estradiol hemihydrate. Eur J Pharm Biopharm 49:237-242. (Pubitemid 30229872)
20. Lee W-F, Jou L-L. 2004. Effect of intercalation agent content of montmorillonite on the swelling behaviour and drug release behaviour of nanocomposite hydrogels. J Appl Polym Sci 94:74-82.
21. Cypes SH, Saltzman WM, Giannelis EP. 2003. Organosilicate polymer drug delivery systems - Controlled release and enhanced mechanical properties. J Control Release 90:163-169.
22. Dong Y, Feng S-S. 2005. Poly(D,L-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs. Biomaterials 26:6068-6076. (Pubitemid 40805612)
23. Carretero MI. 2002. Clay minerals and their beneficial effects upon human health: A review. Appl Clay Sci 21:155-163.
24. Lin FH, Chen C-H, Cheng WTK, Kuo TF. 2006. Modified montmorillonite as vector for gene delivery. Biomaterials 27:3333-3338. (Pubitemid 43344344)
25. Cavallaro G, Pierro P, Palumbo FS, Testa F, Pasqua L, Aiello R. 2004. Drug delivery devices based on mesoporous silicate. Drug Deliv 11:41-46. (Pubitemid 38292726)
26. Desigaux L, Belkacem MB, Richard P, Cellier J, Leone P, Cario LF, Leroux F, Taviot-Gueho C, Pitard B. 2006. Self-assembly and characterization of layered double hydroxide/DNA hybrids. Nano Lett 6:199-204. (Pubitemid 43382951)
27. Harrison KL, Jenkins MJ. 2004. The effect of crystallinity and water absorption on the dynamic relaxation behaviour of polycaprolactone. Polym Int 53:1298-1304.
28. Wang Y, Rodriguez-Perez MA, Reiss RL, Mano JF. 2005. Thermal and thermomechanical behaviour of polycaprolactone and starch/polycaprolectone blends for biomedical applications. Macromol Mater Eng 290:792-801. (Pubitemid 41263308)
29. Rich J, Kortesuo P, Yli-Urpo A, Kiesvaara J, Seppala J. 2001. Effect of the molecular weight of poly(epsilon-caprolactone-co-DL-lactide) on toremifene citrate release from copolymer/silica xerogel composites. Int J Pharm 212:121-130. (Pubitemid 32121957)
30. Chang H-I, Williamson MR, Perrie Y, Coombes AGA. 2005. Precipitation casting of drug-loaded microporous PCL matrices: Incorporation of progesterone by co-dissolution. J Control Release 106:263-272. (Pubitemid 41187436)
31. Lyons JG, Holehonnur H, Devine DM, Kennedy JE, Geever LM, Blackie P, Higginbottom CL. 2007. The significance of variation in extrusion speeds and temperatures on a PEO/PCL blend based matrix for oral drug delivery. Mater Chem Phys 103:419-426.
32. Campbell K, Craig DQM, McNally T. 2008. Poly(ethylene glycol) layered silicate nanocomposites for retarded drug release prepared by hot-melt extrusion. Int J Pharm 363:126-131.
33. Jimenez G, Ogata N, Kawai H, Ogihara T. 1997. Structure and thermal/mechanical properties of poly(e-caprolactone)-clay blend. J Appl Polym Sci 64:2211-2220. (Pubitemid 127560495)
34. Nichols G, Frampton CS. 1998. Physiochemical characterization of the orthorhombic polymorph of paracetamol crystallized from solution. J Pharm Sci 82:684-693.
35. Chawla N, Sidhu RS, Ganesh VV. 2006. Three-dimensional visualization and microstructure-based modeling of deformation in particle-reinforced composites. Acta Mater 54:1541-1548. (Pubitemid 43277758)
36. Rezgui F, Swistek M, Hiver JMG, Sell C, Sadoun T. 2005. Deformation and damage upon stretching of degradable polymers (PLA and PCL). Polymer 46:7370-7385. (Pubitemid 41125194)
37. Fornes TD, Paul DR. 2003. Modeling properties of nylon6/clay nanocomposites using composite theories. Polymer 44:4993-5013.
38. Finnigan B, Jack K, Campbell K, Halley P, Truss R, Casey P, Cookson D, King S, Martin D. 2005. Segmented polyurethane nanocomposites: Impact of controlled particle size nanofillers on the morphological response to uniaxial deformation. Macromolecules 38:7386-7396. (Pubitemid 41305039)
39. Pantoustier N, Alexandre M, Degee P, Calberg C, Jerome R, Henrist C. 2001. Poly(e-caprolactone) layered silicate nanocomposites: Effect of clay surface modifiers on the melt intercalation process. e-Polymers 9:1-9.
40. Kalambur S, Rizvi SSH. 2005. Biodegradable and functionally superior starch-polyester nanocomposites from reactive extrusion. J Appl Polym Sci 96:1072-1082. (Pubitemid 40566887)
41. United States Pharmacopeial Convention Inc. 2005. In vitro and in vivo evaluation of dosage forms. Rockville, MD: United States Pharmacopeial Convention Inc. p. 1088.
42. Pena J, Corrales T, Izquierdo-Barba I, Doadrio AL, Vallet-Regi M. 2006. Long term degradation of poly(e-caprolactone) films in biologically related fluids. Polym Degrad Stabil 91:1424-1432.
43. Lloyd GR, Craig DQM, Smith A. 1999. A calorimetric investigation into the interaction between paracetamol and polyethylene glycol 4000 in physical mixes and solid dispersions. Eur J Pharm Biopharm 48:59-65. (Pubitemid 29308927)
44. Granberg RA, Rasmuson AC. 1999. Solubility of paracetamol in pure solvents. J Chem Eng Data 44:1391-1395.
45. Liu J, Li L, Cai Y. 2006. Immobilization of camptothecin with surfactant into hydrogel for controlled drug release. Eur Polym J 42:1767-1774. (Pubitemid 44015737)